Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142.
Saved in:
| Title: | Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142. |
|---|---|
| Authors: | André, T.1,2 (AUTHOR) thierry.andre@aphp.fr, Lonardi, S.3 (AUTHOR), Wong, K.Y.M.4 (AUTHOR), Lenz, H.-J.5 (AUTHOR), Gelsomino, F.6 (AUTHOR), Aglietta, M.7,8 (AUTHOR), Morse, M.A.9 (AUTHOR), Van Cutsem, E.10 (AUTHOR), McDermott, R.11 (AUTHOR), Hill, A.12 (AUTHOR), Sawyer, M.B.13 (AUTHOR), Hendlisz, A.14 (AUTHOR), Neyns, B.15 (AUTHOR), Abdullaev, S.16 (AUTHOR), Memaj, A.17 (AUTHOR), Lei, M.18 (AUTHOR), Dixon, M.19 (AUTHOR), Kopetz, S.20 (AUTHOR), Overman, M.J.20 (AUTHOR) |
| Source: | Annals of Oncology. Oct2022, Vol. 33 Issue 10, p1052-1060. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.06.008 |
